154 related articles for article (PubMed ID: 3008128)
1. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
Sosnowski M
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
[No Abstract] [Full Text] [Related]
2. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole: a comprehensive review.
Massoomi F; Savage J; Destache CJ
Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
[TBL] [Abstract][Full Text] [Related]
5. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
Lamers CB
Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
[TBL] [Abstract][Full Text] [Related]
6. [Omeprazole].
Isal JP
Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
[No Abstract] [Full Text] [Related]
7. Pump blockers and ulcer disease.
Sachs G
N Engl J Med; 1984 Mar; 310(12):785-6. PubMed ID: 6230536
[No Abstract] [Full Text] [Related]
8. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
[TBL] [Abstract][Full Text] [Related]
9. [Omeprazole. A new substance for inhibiting acid production].
Uhl D
Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691
[No Abstract] [Full Text] [Related]
10. Pharmacologic control of gastric acid secretion in peptic ulcer.
Konturek SJ
Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
[No Abstract] [Full Text] [Related]
11. [Inhibitors of proton pump in the treatment of Zollinger-Ellison syndrome].
Kubyshkin VA; Kochatkov AV
Khirurgiia (Mosk); 2012; (12):67-71. PubMed ID: 23323285
[No Abstract] [Full Text] [Related]
12. [Omeprazole and inhibition of gastric acid secretion].
Rossi G
Recenti Prog Med; 1984 Apr; 75(4):419-21. PubMed ID: 6729204
[No Abstract] [Full Text] [Related]
13. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
Lamers CB
Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
[No Abstract] [Full Text] [Related]
14. [Substituted benzimidazoles--a new dimension in ulcer therapy?].
Fimmel CJ; Blum AL
Wien Klin Wochenschr; 1984 Feb; 96(4):149-53. PubMed ID: 6324498
[TBL] [Abstract][Full Text] [Related]
15. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole.
Med Lett Drugs Ther; 1990 Mar; 32(813):19-21. PubMed ID: 2179694
[No Abstract] [Full Text] [Related]
17. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
Arnold R
Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
[No Abstract] [Full Text] [Related]
18. Treatment of patients with Zollinger-Ellison syndrome.
Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
[TBL] [Abstract][Full Text] [Related]
19. [Proton pump blockers and their significance in gastroenterology].
Dítĕ P; Prásek J
Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340
[TBL] [Abstract][Full Text] [Related]
20. [Omeprazole, the drug of the future for the treatment of Zollinger-Ellison syndrome and duodenal ulcer?].
Fiasse R; Tomé G; Dive C
Acta Gastroenterol Belg; 1984; 47(6):555-68. PubMed ID: 6537111
[No Abstract] [Full Text] [Related]
[Next] [New Search]